EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A MR Fingerprinting Development Kit for Quantitative 3D Brain Imaging

Rasim Boyacioglu iD, Thomas Kluge, Guido Buonincontri iD, Wei-Ching Lo, Stephan Kannengiesser, Mathias Nittka, Arashdeep Kaur, Andrew Dupuis, Dan Ma, Chaitra Badve iD, Mark A Griswold, Yong Chen iD

Journal of Magnetic Resonance Imaging · 2026-07 · 64 (1) · 209-217

DOI: 10.1002/jmri.70320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 28.03.2026. Verfasst von Rasim Boyacioglu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Imaging, Three-Dimensional, Brain Neoplasms, Magnetic Resonance Imaging, Brain. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Siemens Healthineers, NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Magnetic resonance fingerprinting (MRF) is an emerging quantitative imaging technique that enables multiparametric tissue characterization, but its adoption has been hindered by the complexity of data acquisition and post‐processing. These technical and implementation challenges have limited its broader clinical deployment.

Purpose

To develop a modular MRF Development Kit (MRFDK) that enables efficient sequence design, streamlined implementation, and real‐time image reconstruction. Study Type Prospective. Population T 1 and T 2 relaxation phantom, nine volunteers (seven males and two females), five metastatic brain cancer patients. Field Strength/Sequence 3 T, MR Fingerprinting. Assessment Accuracy of T 1 and T 2 quantification was estimated from phantom experiments. Manual ROIs were drawn on brain lesions and contralateral white matter for metastatic cancer patients. Statistical Tests t ‐test, in vivo repeatability was calculated with Bland–Altman analysis on healthy volunteer scan‐rescan data, significance level p < 0.01.

Results

Phantom results showed high accuracy in T 1 and T 2 assessment, with absolute percentage differences of 3% for T 1 and 5% for T 2 compared to offline MATLAB reconstruction. In vivo scans of eight healthy subjects further demonstrated excellent repeatability (bias and agreement: 0.95% ± 1.85% for T 1 ; 1.78% ± 5.08% for T 2 ). In patients, metastatic lesions showed significantly higher T 1 and T 2 values (T 1 , 1474 ms; T 2 , 61 ms) compared to normal white matter (T 1 , 913 ms; T 2 , 38 ms). With integrated B 1 correction, all T 1 and T 2 maps were available for visualization within 1 min post‐MRF scan, enabling immediate image assessment. Data Conclusion A modular MRF development package enabling efficient 3D acquisition and rapid inline reconstruction was developed and evaluated in this study. Level of Evidence 1. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Imaging, Three-DimensionalBrain NeoplasmsMagnetic Resonance ImagingBrainImage Processing, Computer-AssistedHumansFemalePhantoms, ImagingReproducibility of ResultsMaleProspective StudiesAdultMiddle AgedAlgorithmsWhite MatterImage Interpretation, Computer-AssistedHealthy Volunteers

Stichwörter der Autor:innen

Bland–AltmanMRFaccuracyclinical translationmappingmetastasisquantitative MRIrelaxationrepeatability

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
  • Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany.
  • Siemens Medical Solutions, Boston, Massachusetts, USA.
  • Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
  • Department of Radiology, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Neurosurgery, Duke University, Durham, North Carolina, USA.

ORCID-Profile: Rasim Boyacioglu, Guido Buonincontri, Chaitra Badve, Yong Chen

Förderung

  • Siemens Healthineers
  • NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Boyacioglu, R., Kluge, T., Buonincontri, G., Lo, W. C., Kannengiesser, S., Nittka, M., Kaur, A., Dupuis, A., Ma, D., Badve, C., A Griswold, M., & Chen, Y. (2026). A MR Fingerprinting Development Kit for Quantitative 3D Brain Imaging. Journal of Magnetic Resonance Imaging, 64(1), 209-217. https://doi.org/10.1002/jmri.70320

Vancouver

Boyacioglu R, Kluge T, Buonincontri G, Lo WC, Kannengiesser S, Nittka M, et al. A MR Fingerprinting Development Kit for Quantitative 3D Brain Imaging. Journal of Magnetic Resonance Imaging. 2026;64(1):209-217. doi:10.1002/jmri.70320

BibTeX
@article{Boyacioglu2026,
  author = {Boyacioglu, Rasim and Kluge, Thomas and Buonincontri, Guido and Lo, Wei-Ching and Kannengiesser, Stephan and Nittka, Mathias and Kaur, Arashdeep and Dupuis, Andrew and Ma, Dan and Badve, Chaitra and A Griswold, Mark and Chen, Yong},
  title = {A MR Fingerprinting Development Kit for Quantitative 3D Brain Imaging},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2026},
  volume = {64},
  number = {1},
  pages = {209--217},
  doi = {10.1002/jmri.70320}
}
Kostenlos starten →